Medicare Advantage and Prescription Drug Program: Communications and Marketing Provisions (CMS-10837)

The statutory provisions help ensure Medicare beneficiaries are informed and protected when making an election to enroll in an MA (including MAPD) or Part D plan. We believe the regulations strengthen CMS’ ability to ensure that MA and Part D marketing to beneficiaries is not misleading, inaccurate, or confusing. Additionally, under 42 CFR 417.428, most marketing requirements in subpart V of part 422 also apply to section 1876 cost plans.

The latest form for Medicare Advantage and Prescription Drug Program: Communications and Marketing Provisions (CMS-10837) expires 2026-08-31 and can be found here.